Lab tests show pp 332 activation leads to suppression of lipogenic gene expression and activation of genes involved in mitochondrial biogenesis
If you cannot tolerate GLP-1 agonists, have only modest fat loss goals, or want to add a well-tolerated compound to an existing protocol, AOD 9604 might have a place
Some combinations are researched (like future CagriSema), but most fat loss peptides shouldn't be stacked due to overlapping pathways
Which one is assigned to you may depend on your state and the specific therapy - the brand states this is disclosed in your order confirmation
Next, we clean the injection site, typically the thigh, upper arm, or abdomen, with an alcohol wipe and allow it to dry completely to minimize irritation